UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011998
Receipt number R000014025
Scientific Title Efficacy and safety of imidafenacin in female overactive bladder patients with hypertension.
Date of disclosure of the study information 2013/10/15
Last modified on 2013/10/09 14:28:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy and safety of imidafenacin in female overactive bladder patients with hypertension.

Acronym

Efficacy and safety of imidafenacin in female overactive bladder patients with hypertension.(East Noah Study)

Scientific Title

Efficacy and safety of imidafenacin in female overactive bladder patients with hypertension.

Scientific Title:Acronym

Efficacy and safety of imidafenacin in female overactive bladder patients with hypertension.(East Noah Study)

Region

Japan


Condition

Condition

overactive bladder

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy and safety of imidafenacin in female overactive patients with or without hypertension.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

overactive bladder symptom score

Key secondary outcomes

frequency volume chart, Athens Insomnia Scale Actigram, Nocturia Quality-of-Life Questionnare, adverse effects, patient background, uroflowmetry, residual urine volume


Base

Study type

Interventional


Study design

Basic design

Factorial

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of imidafenacin

Interventions/Control_2

hypertension

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

overactive bladder patients and whose OABSS Q2 score is over 2 and Q3 is over 2

Key exclusion criteria

stress urinary incontinence patient, patient who have urinary dysfunction, allergy for anticholinergic agents

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yukiko Kouchi

Organization

Tokyo Women's Medical University Hospital

Division name

Department of Urology

Zip code


Address

Kawadacho 8-1, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-8111

Email

ykouchi@kc.twmu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukiko Kouchi

Organization

Tokyo Women's Medical University Hospital

Division name

Department of Urology

Zip code


Address

Kawadacho 8-1, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-8111

Homepage URL


Email

ykouchi@kc.twmu.ac.jp


Sponsor or person

Institute

Department of Urology, Tokyo Women's Medical University

Institute

Department

Personal name



Funding Source

Organization

Department of Urology, Tokyo Women's Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京女子医科大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2013 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2013 Year 10 Month 02 Day

Date of IRB


Anticipated trial start date

2013 Year 11 Month 01 Day

Last follow-up date

2015 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 10 Month 09 Day

Last modified on

2013 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014025


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name